An interventional study of Algorithm and Random Match in Caregiver Stress, Dementia and Alzheimer Disease, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Mayo Clinic · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 228 studies in Caregiver Burden with a site in United States — 59 open to participants now, 71 under way, 1 of them phase 3. Caregiver Burden · United States.
Among the 228 studies in Caregiver Burden with a site in United States, this one is the 13th largest by enrollment of the 208 interventional ones that give a count, is one of 33 that started in 2023, is one of 190 with no phase, and was the 128th registered.
503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.
Browse Caregiver Burden studies →59 of the 228 studies in Caregiver Burden with a site in United States are open now. Recruiting first, the newest first:
University of Washington · Sites in United States
Ages 18+
Ohio State University · Sites in United States
Ages 18+
Massachusetts General Hospital · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18+ · Healthy volunteers
The University of Texas Medical Branch, Galveston · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
228 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 9 · Phase 3 4 · Phase 4 2
First in 2000; this study’s year is marked. 33 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 420 is above the median of 73 across 404 interventional studies indexed under Caregiver Burden.
Median enrollment 60 across the 208 interventional studies, 47 across the 19 observational. Of the 140 that completed or were terminated, 54 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
14 of 228 have an industry lead sponsor. The 10 most frequent:
Mayo Clinic is the lead sponsor of 3,272 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 322 (71%) have results posted.
Mayo Clinic has 4 studies filed under Caregiver Burden — fewer than ten, so there is no comparison to draw.
29 of the studies in Caregiver Burden with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06167746Phase 3University of PennsylvaniaiCare4Me Transitions | 2027-09-30 |
| NCT05543681IGC Pharma, LLCClinical Trial on Agitation in Alzheimer's Dementia | 2026-11 |
| NCT06099197Indiana UniversityI-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals | 2026-11 |
| NCT07594730New York State Psychiatric InstituteBrief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems | 2026-12-01 |
| NCT06460012Oregon Health and Science UniversitySupport Via Technology: Living and Learning With Advancing Dementia-REVISED | 2026-12-01 |
Add all 29 to your calendar (.ics) → With an account.
Among the 228 studies in Caregiver Burden with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This research is being done to develop a unique matching process for caregivers of persons living with dementia, such as Alzheimer's disease, Lewy body dementia, frontotemporal degeneration, or other dementia syndromes. Dementia caregivers often assume greater caregiving burden than do non-dementia caregivers, and the caregiving duration tends to be longer. Many caregivers do not have the adequate support they need. Peer-to-peer support has been shown to improve quality of life, more engagement with services, improve caregiver health, and reduce hospitalizations in the person they are caring for. This study will help determine whether caregivers of persons with dementia would find a technology-based caregiver matching program valuable for the purpose of emotional support.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals that identify as a current and/or former caregiver for a person with dementia will be matched to other caregivers using an algorithm that matches a caregiver to another caregiver based on specific preferences each caregiver identifies in a questionnaire.
Behavioral: Algorithm
Individuals that identify as a current and/or former caregiver for a person with dementia will be randomly matched to other caregivers not based on the preferences they identified in a questionnaire.
Behavioral: Random Match
For purpose of finding peer-to-peer support, current and/or former caregivers of persons with dementia will be matched using an algorithm. They can then choose make a connection and maintain a connection for the duration of the study.
For purpose of finding peer-to-peer support, current and/or former caregivers of persons with dementia will be randomly matched. They can then choose make a connection and maintain a connection for the duration of the study.
Match Satisfaction Questionnaire
All participants will complete a match satisfaction questionnaire to assess whether being matched to a supportive caregiver via an algorithm based on personal preferences results in greater match satisfaction than being matched at random. Questions are scored from 0 to 4 with a possible total of 28. Scores are interpreted such that an overall total of: 0 - 7 = low satisfaction; 8-14 = medium/average satisfaction; 15-28 = high satisfaction
Time frame: 12 months
Change over time from Baseline Resilience to 12 months
All participants will complete questions surveying resilience to determine whether caregivers randomized to algorithmic matching based on personal preferences will report a greater sense of resiliency after being matched than caregivers who are randomly matched.
Time frame: Baseline, 12 months
Change over time from Baseline Quality of Life to 12 months
All participants will complete questions surveying quality of life to determine whether caregivers randomized to algorithmic matching based on personal preferences will report improved quality of life after being matched than caregivers who are randomly matched.
Time frame: Baseline, 12 months
Scale of Perceived Social Support
All participants will complete survey questions regarding perceived level of social support to assess impact on match satisfaction.
Time frame: 12 months
Survey of Executive Skills
All participants will complete questions regarding executive functioning (e.g., flexibility, problem-solving) to determine whether the level of these skills relates to ease or difficulty in finding a satisfactory supportive caregiver match.
Time frame: 12 months
Plan to share: No
Ran from Feb 2023 to primary completion in Mar 2026, 37 months.
Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's 37 months is above that.
Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Jul 2026 → Mar 2026 and completion Jul 2026 → Mar 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.